Videos de Experimentos Relacionados
Pérdida súbita de la visión.
1Normanby Building, Kings College Hospital, London, UK. jaheedkhan@yahoo.co.uk
Lancet (London, England)
|August 21, 2007
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Utility, validity, feasibility and acceptability of a clinician-administered depression, two-question screening tool for routine multiple sclerosis clinic administration.
Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author
Novel drug development for geographic atrophy.
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)·2026
Same author
Immunotherapies in neuromyelitis optica: Bayesian network meta-analysis.
Journal of neurology·2025
Same author
Electrodiagnostic Tests as Potential Efficacy Endpoints in Clinical Trials of Novel Pharmacological Therapies for Acquired Retinal Disorders.
Ophthalmic research·2025
Same author
Edridge Green Lecture 2022-demystifying clinical trials and regulatory approvals in drug development.
Eye (London, England)·2024
Same author
Adjudication of Hospitalizations and Deaths in the IRONMAN Trial of Intravenous Iron for Heart Failure.
Journal of the American College of Cardiology·2024
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026